Navigation

HIDE

Weather Location

PPI & Prokinetics - Boon for Diabetic Gastroparesis

Parveen Malhotra*, Naveen Malhotra, Vani Malhotra, Aman Gupta, Pansi Gupta Ajay Chugh, Abhishek Chaturvedi, Parul Chandrika
Received: 03 August 2015 / Received in revised form: 05 February 2016, Accepted: 31 May 2016 Published on…

Parveen Malhotra*, Naveen Malhotra, Vani Malhotra, Aman Gupta, Pansi Gupta Ajay Chugh, Abhishek Chaturvedi, Parul Chandrika

Received: 03 August 2015 / Received in revised form: 05 February 2016, Accepted: 31 May 2016 Published online: 26 June 2016;

Abstract

Diabetes is one of the common causes of gastroparesis, with data suggesting that approximately 5 to 12% patients with diabetes have symptoms consistent with gastroparesis. A 60-year-old male, who was a known diabetic for last 20 years and had been on regular oral hypoglycemic, presented with complaints of early satiety, bloating, and abdominal distension for last 10 years on and off. He was being treated with proton pump inhibitors (PPIs) for long duration but without any substantial relief. In terms of biochemical parameters, patient was seen to be having uncontrolled glucose levels both in fasting and postprandial levels. The patient was diagnosed to be suffering from diabetic Gastroparesis and his oral hypoglycemic agents were changed so that his glucose levels were controlled. Further, to manage gastrointestinal symptoms and underlying gastroparesis due to which patient was symptomatic, he was put on combination of PPI (pantoprazole) plus levosulpiride 75 mg per day.

Keywords:  Non-alcoholic fatty liver disease, Liver fibrosis, Liver biopsy, Diabetes Mellitus, Metabolic Syndrome

Download PDF

Citation: Parveen Malhotra*, Naveen Malhotra, Vani Malhotra, Aman Gupta, Pansi Gupta Ajay Chugh, Abhishek Chaturvedi, Parul Chandrika (2016) PPI & Prokinetics - Boon for Diabetic Gastroparesis, Journal of Nutrition Research, Vol. 4, Issue 1, pp. 85-87


© The Indian Association for Parenteral and Enteral Nutrition 2016

No comments